---
permalink: /
title: "About me"
excerpt: "About me"
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---

My name is Xuanyu Shi.

I am currently a Health Data Science PhD Candidate at the National Institute of Health Data Science, Peking University. My research interests include biomedical literature mining, automatic evidence synthesis, health causal knowledge network, and AI for evidence-based medicine.

My PhD supervisor: [Dr. Jian Du](https://www.nihds.pku.edu.cn/en/info/1027/1024.htm)

Education
======

2022-2026, PhD, Health Data Science, Peking University, Beijing, China \
2018-2020, MS, Data Science, Drexel University, Philadelphia, PA, USA \
2013-2017, BS, Statistics, University of Iowa, Iowa City, IA, USA

Working Experience
======

2020-2022, Research assistant, National Institute of Health Data Science, Peking University, Beijing, China \
2018-2018, Summer intern, Department of Data Platform, Megvii, Beijing, China \
2017-2018, Business analyst intern, Forepont Capital Partners, New York, NY, USA \
2016-2016, Risk management intern, Department of Risk Management, Generali China, Beijing, China

Academic Services
======

Conference reviewer:
- AMIA 2025

Journal reviewer:
- Health Data Science
- Frontiers in Endocrinology
- Frontiers in Public Health

Publications {#publications}
======

**[<span style="color: blue; font-weight: bold;">1st author</span>, Nature Communications 2025]** **Xuanyu Shi**, Wenjing Zhao, Ting Chen, Chao Yang, Jian Du. [Evidence triangulator: using large language models to extract and synthesize causal evidence across study designs](https://www.nature.com/articles/s41467-025-62783-x). Nature Communications, 2025, 16: 7355.

**[Science Bulletin 2025]** Xin Guo, Jiakang Huo, Wanwei Dai, Tong Wang, Han Xiao, Wenjing Zhao, **Xuanyu Shi**, Xueheng Wang, Yang Gao, Zhi Li, Rui Zhan, Wenli Xu, Jian Du, Erdan Dong. [Global rehabilitation research equality index across health conditions during 1990–2019: an alignment analysis between bibliographic and epidemiological data](https://www.sciencedirect.com/science/article/pii/S2095927325001744). Science Bulletin, 2025, 70(7): 1057-1061.

**[Annals of the New York Academy of Sciences 2025]** Liubai Li, Jian Du, Feng Sun, Zhixia Li, Tianjiao Chen, **Xuanyu Shi**. [Diet therapy for the management of obesity in children and adolescents: Overview of systematic reviews and meta‐analysis of randomized controlled trials](https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/nyas.15307). Annals of the New York Academy of Sciences, 2025, 1547(1): 41-51.

**[Annals of the New York Academy of Sciences 2025]** Liubai Li, Feng Sun, Jian Du, Zhixia Li, Tianjiao Chen, **Xuanyu Shi**. [Behavior‐change lifestyle interventions for the treatment of obesity in children and adolescents: A scoping review](https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/nyas.15278). Annals of the New York Academy of Sciences, 2025, 1543(1): 31-41.

**[<span style="color: blue; font-weight: bold;">1st author</span>, Health Data Science 2024]** **Xuanyu Shi**, Daoxin Yin, Yongmei Bai, Wenjing Zhao, Xin Guo, Huage Sun, Dongliang Cui, Jian Du. [A Bibliographic Dataset of Health Artificial Intelligence Research](https://spj.science.org/doi/full/10.34133/hds.0125). Health Data Science, 2024, 4: 0125.

**[<span style="color: blue; font-weight: bold;">1st author</span>, Preprint 2024]** **Xuanyu Shi**, Wenjing Zhao, Ting Chen, Chao Yang, Jian Du. [A Large Language Model Approach to Extracting Causal Evidence across Study Designs for Evidence Triangulation](https://www.medrxiv.org/content/10.1101/2024.03.18.24304457v3). 2024.

**[Journal of Evidence‐Based Medicine 2024]** Yongmei Bai, **Xuanyu Shi**, Jian Du. [A computable biomedical knowledge system: Toward rapidly building candidate‐directed acyclic graphs](https://onlinelibrary.wiley.com/doi/abs/10.1111/jebm.12602). Journal of Evidence‐Based Medicine, 2024, 17(2): 307-316.

**[<span style="color: blue; font-weight: bold;">1st author</span>, Scientific Data 2024]** **Xuanyu Shi**, Jian Du. [Constructing a finer-grained representation of clinical trial results from ClinicalTrials.gov](https://www.nature.com/articles/s41597-023-02869-7). Scientific Data, 2024, 11(1): 41.

**[<span style="color: blue; font-weight: bold;">1st author</span>, Journal of Informetrics 2022]** **Xuanyu Shi**, Jian Du. [Distinguishing transformative from incremental clinical evidence: A classifier of clinical research using textual features from abstracts and citing sentences](https://www.sciencedirect.com/science/article/pii/S1751157722000141). Journal of Informetrics, 2022, 16(2): 101262.

**[Frontiers of Medicine 2022]** Huai-yu Wang, Suyuan Peng, Zhanghui Ye, Pengfei Li, Qing Li, **Xuanyu Shi**, Rui Zeng, Ying Yao, Fan He, Junhua Li, Liu Liu, Shuwang Ge, Xianjun Ke, Zhibin Zhou, Gang Xu, Ming-hui Zhao, Haibo Wang, Luxia Zhang, Erdan Dong. [Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension](https://link.springer.com/article/10.1007/s11684-021-0850-9). Frontiers of Medicine, 2022, 16(1): 102-110.

**[Nephrology Dialysis Transplantation 2020]** Suyuan Peng, Huai-Yu Wang, Xiaoyu Sun, Pengfei Li, Zhanghui Ye, Qing Li, Jinwei Wang, **Xuanyu Shi**, Liu Liu, Ying Yao, Rui Zeng, Fan He, Junhua Li, Shuwang Ge, Xianjun Ke, Zhibin Zhou, Erdan Dong, Haibo Wang, Gang Xu, Luxia Zhang, Ming-Hui Zhao. [Early versus late acute kidney injury among patients with COVID-19—a multicenter study from Wuhan, China](https://academic.oup.com/ndt/article-abstract/35/12/2095/6020340). Nephrology Dialysis Transplantation, 2020, 35(12): 2095-2102.
